Heart complications in familial transthyretin amyloidosis: Impact of age and gender

Amyloid

Volumn 17, Issue 2, 2010, Pages 63-68

  Hörnsten, Rolf ^a,b   Pennlert, Johanna ^b   Wiklund, Urban ^a   Lindqvist, Per ^a,b   Jensen, Steen M ^a,b   Suhr, Ole B ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Arrhythmia; Echocardiography; FAP; Holter

Indexed keywords

AMYLOID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; PREALBUMIN;

ADULT; AGE; AGED; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE DURATION; ECHOCARDIOGRAPHY; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GENDER; HEART ARRHYTHMIA; HEART ATRIUM; HEART HYPERTROPHY; HEART MUSCLE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART SIZE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HOLTER MONITORING; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE; SYMPTOM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AMYLOID NEUROPATHIES, FAMILIAL; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; PREALBUMIN; SEX FACTORS;

EID: 77952563467     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2010.483114     Document Type: Article

References (31)

1. Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408-427.
2. Steen L, Holmgren G, Suhr O, Wikström L, Groth CG, Ericzon BG. Worldwide survey of liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid 1994;1:138-142.
3. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057-1062.
4. Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP) -type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995;60:512-521.
5. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993;43:288-294.
6. Frederiksen T, Gotzsche H, Harboe N, Kiaer W, Mellemgaard K. Familial primary amyloidosis with severe amyloid heart disease. Am J Med 1962;33:328-348.
7. Benson MD, Wallace MR, Tejada E, Baumann H, Page B. Hereditary amyloidosis: description of a new American kindred with late onset cardiomyopathy. Appalachian amyloid. Arthritis Rheum 1987;30:195-200.
8. Beckman A, Bjerle P, Olofsson B. Electrocardiographic findings in familial amyloidotic polyneuropathy. Am J Noninvas Cardiol 1992;6:192-196.
9. Hörnsten R, Wiklund U, Olofsson BO, Jensen SM, Suhr OB. Liver transplantation does not prevent the development of life threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation 2004;78:112-116.
10. Suhr OB, Lindqvist P, Olofsson BO, Waldenstrom A, Backman C. Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy. Amyloid: J Protein Folding Disord 2006;13:154-159.
11. Rapezzi C, Riva L, Quarta CC, Perugini E, Salvi F, Longhi S, Ciliberti P, Pastorelli F, Biagini E, Leone O et al. Genderrelated risk of myocardial involvement in systemic amyloidosis. Amyloid 2008;15:40-48.
12. Olofsson BO, Backman C, Boman K. Echocardiographic assessment of the course of heart disease in familial amyloidotic polyneuropathy. Am J Noninvas Cardiol 1988;2:300-305.
13. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994;235:479-485.
14. Olofsson BO, Backman C, Karp K, Suhr O. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy. Transplantation 2002;73 745-751. (Pubitemid 34260571)
15. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB, Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998;66:229-233.
16. Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, Baba S, Kametani F, Ikeda S. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 2000;274:702-706.
17. Engel G, Beckerman JG, Froelicher VF, Yamazaki T, Chen HA, Richardson K, McAuley RJ, Ashley EA, Chun S, Wang PJ. Electrocardiographic arrhythmia risk testing. Curr Probl Cardiol 2004;29:365-432.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
19. Hellman U, Alarcon F, Lundgren HE, Suhr OB, Bonaiti-Pellie C, Plante-Bordeneuve V. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid 2008;15:181-186.
20. Falcao De Freitas A, Barbedo A. Conduction disturbances in 190 patients with familial amyloidotic polyneuropathy (Andrade's type). Adv Cardiol 1978;21:206-209.
21. Sawayama T, Kurihara T, Araki S. Noninvasive cardiovascular findings in familial amyloid polyneuropathy. Br Heart J 1978;40:1288-1292.
22. Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005;165:1425-1429.
23. Hattori T, Takei Y, Koyama J, Nakazato M, Ikeda S. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Amyloid 2003;10:229-239. (Pubitemid 38120397)
24. Goncalves I, Alves CH, Quintela T, Baltazar G, Socorro S, Saraiva MJ, Abreu R, Santos CR. Transthyretin is upregulated by sex hormones in mice liver. Mol Cell Biochem 2008;317:137-142.
25. Johansson B, Westermark P. Senile systemic amyloidosis: a clinico-pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991;32:83-92.
26. Westermark P, Bergstrom J, Solomon A, Murphy C, Sletten K. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid: J Protein Folding Disord 2003;1(10 Suppl.): 48-54.
27. Falk RH, Rubinow A, Cohen AS. Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol 1984;3:107-113.
28. Hörnsten R, Wiklund U, Suhr OB, Jensen SM. Ventricular late potentials in familial amyloidotic polyneuropathy. J Electrocardiol 2006;39:57-62.
29. Bergstrom J, Gustavsson A, Hellman U, Sletten K, Murphy CL, Weiss DT, Solomon A, Olofsson BO, Westermark P. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol 2005;206:224-232.
30. Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol 2008;216:253-261.
31. Suhr OB, Anan I, Backman C, Karlsson A, Lindqvist P, Morner S, Waldenstrom A. Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis? J Intern Med 2008;263:294-301.